FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

894311000001106: Naprosyn 250mg tablets (Roche Products Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16602301000001112 Naprosyn 250mg tablets (Roche Products Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
100395601000001119 Naprosyn 250mg tablets (Atnahs Pharma UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Naprosyn 250mg tablets (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Naprosyn 250mg tablets (Roche Products Ltd) Is a Product containing precisely naproxen 250 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Naprosyn 250mg tablets (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Naprosyn 250mg tablets (Roche Products Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Naprosyn 250mg tablets (Roche Products Ltd) Is a Naproxen 250mg tablets true Inferred relationship Existential restriction modifier
Naprosyn 250mg tablets (Roche Products Ltd) Has active ingredient Naproxen false Inferred relationship Existential restriction modifier
Naprosyn 250mg tablets (Roche Products Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Naprosyn 250mg tablets (Roche Products Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Naprosyn 250mg tablets (Roche Products Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Naprosyn 250mg tablets (Roche Products Ltd) Is a Naprosyn true Inferred relationship Existential restriction modifier
Naprosyn 250mg tablets (Roche Products Ltd) Has specific active ingredient Naproxen true Inferred relationship Existential restriction modifier
Naprosyn 250mg tablets (Roche Products Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Naprosyn 250mg tablets (Roche Products Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Naprosyn 250mg tablets (Roche Products Ltd) 56 tablet 4 x 14 tablets Is pack of False Naprosyn 250mg tablets (Roche Products Ltd) Inferred relationship Existential restriction modifier
Naprosyn 250mg tablets (Roche Products Ltd) 56 tablet 4 x 14 tablets Has AMP True Naprosyn 250mg tablets (Roche Products Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start